HLA-A and acute myeloid leukemia: In conclusion, we isolated a T-cell clone for YTDVSNMSHLA showing a specific recognition and lysis of patient-derived AML cells, thereby validating this peptide as a neoantigen that can be targeted in HLA-A*01:01-positive AML with DNMT3AR882H.